Dairy Products: Pro- or Anti
Transcription
Dairy Products: Pro- or Anti
13/05/2013 Dairy Products: Pro- or AntiInflammatory Foods? An Overview Marie-Ève Labonté, Patrick Couture, Benoît Lamarche INAF, Université Laval Inflammation STELA Symposium 2013 Delta Centre-Ville, Montréal, Qc May 14th 2013 Medzhitov, Nature, 2008:454;428-435 Inflammation: common feature of several multifactorial disorders Sources of inflammatory markers Atherosclerosis Cardiovascular diseases Inflammation IL-6 IL-1β TNF-α MCP-1 Metabolic syndrome CRP Type 2 diabetes Scrivo R, Autoimmun Rev, 2011;10:369-74 Adjusted relative risk of a first cardiovascular event Rader, NEJM, 2000;343:1179-82 Meta-analysis on CRP and the risk of coronary heart disease, stroke and mortality Women’s Health Study The Emerging Risk Factors Collaboration Ridker PM et al. NEJM. 2002;347:1557-65 Lancet 2010;375:132-40 ↑ in the risk associated with a 3-fold ↑ in CRP concentrations* 2.5 2.0 Relative risk* Adiponectin P trend < 0.001 1.5 Coronary heart disease 37% Ischaemic stroke 27% Vascular mortality 55% Non-vascular mortality 54% 1.0 0.5 0.0 1 2 3 4 5 Quintiles of blood CRP concentrations *Ajusted for: age, smoking, type 2 diabetes, blood pressure, hormonal therapy *Ajusted for: age, sex, study, systolic blood pressure, smoking, history of type 2 diabetes, body mass index, triglycerides, cholesterol (total, non-HDL, HDL), alcohol consumption 1 13/05/2013 Factors influencing the inflammatory profile Introduction ● Effects of nutritional factors on inflammatory markers: o Anti-inflammatory : Inflammatory profile o Fruits and vegetables o Whole grains o Fish o Fiber o n-3 fatty acids o Vitamin C and E o Carotenoids o Proinflammatory : o Saturated and trans fatty acids o Western dietary patterns Nanri, Asian Pac J Cancer Prev, 2007;8:167-77 ? Calder PC et al. Br J Nutr. 2011;106:S5-78 Food products allowed and/or forbidden in the hypotoxic diet Dairy products: All dairy products derived from animals are forbidden, including cheese. This also includes milk and cheese from ewes and goats. Translated from: http://jacquelinelagace.net/2012/05/29/aliments-permis-dans-leregime-hypotoxique/ Cell culture studies: ↑ production of proinflammatory cytokines Solis-Pereyra et al. AJCN. 1997;66:521S-5S 2 13/05/2013 Observational studies Observational studies ● ATTICA study Main observation: Panagiotakos et al. J Am Coll Nutr. 2010;29:357-64 1.2 -0.8 0 0.5 1 Dairy product consumption Difference vs. < 8 servings of dairy/week 0% 0.8 Inflammatory 0.4 biomarkers (CRP, IL-6, 0 TNF-α) -0.4 Servings of dairy products per week: -5% -10% 8-11 11-14 > 14 -15% -20% -25% -30% -35% CRP Esmaillzadeh et al. Public Health Nutr. 2010;13:1395-402 Panagiotakos et al. J Am Coll Nutr. 2010;29:357-64 Salas-Salvado et al. Eur J Clin Nutr. 2008;62:651-9 Objective of the presentation ● Systematic review: IL-6 TNF-α Systematic review: eligibility criteria ● Inclusion criteria o o o o Randomized controlled trials Published in English Bovine dairy products (milk, cheese, yogurt) Adult men and women o Low-dairy (control) intervention Labonté et al. Am J Clin Nutr 2013;97:706-17 ● ● Exclusion criteria o o o o o PLI study: “produits laitiers et inflammation” o Randomized crossover nutritional intervention trial o Healthy men and women with low-grade systemic inflammation Pregnant or lactating women Inflammation-related disorders (eg, cancer, arthritis) Lack of a low-dairy intervention Goat milk or soy beverages only High-fat or high-sugar dairy products only (eg, butter, cream, ice cream) Characteristics of the studies included in the systematic review ● Number of studies 8 ● Experimental design: o Parallel 6/8 o Crossover 2/8 ● Subjects: o Overweight or obese o ♂ + ♀ 7/8 o ♀ 1/8 ● Nutritional interventions: o 2 to 3 diets o 4 to 48 weeks Labonté et al. AJCN. 2013 3 13/05/2013 Number of studies Inflammation = Antiinflammatory Proinflammatory Neutral Primary outcome 1 1 0 0 Secondary outcome 5 2 0 3 Undefined outcome 2 TOTAL 1 8 0 4 0 Inflammation as the primary outcome or not ● Heterogeneity + lack of detail regarding tested dairy products ● Difference in the amount of dairy products between the “test” and “control” interventions ● Differences in the nature and the number of inflammatory markers analyzed in each study ● Sensitivity/coefficients of variation of the assays ● Lack of transparency in the report of items associated with the risk of biased results 4 Inflammation = 2 isoenergetic diets of 12 weeks: > 3.5 vs < 0.5 servings of dairy products/d 60% * Number of studies Observed effects Antiinflammatory Proinflammatory Neutral Primary outcome 1 1 0 0 ● Reductions in adiposity indexes Secondary outcome 5 2 0 3 20% ● Adequate power Undefined outcome 2 1 0 1 0% ● Differences in the amount of calcium, milk-derived proteins and bioactive peptides TOTAL 8 4 0 4 -20% * -40% -60% * * * Zemel and Sun. J Nutr. 2008;138:1047-52 CRP Adiponectin +8% -29% +18% Hypoenergetic study Isoenergetic study -11% < 1 serving 3 servings ● Sample size calculation body weight or waist circumference Isoenergetic study *P < 0.02 40% Hypoenergetic study Difference post- vs. pre-diet (high-dairy diet) ● 1 Stancliffe et al. AJCN. 2011;94:422-30 ● Methodological factors limiting the generalizability of results: Observed effects < 1 serving < 1 serving 3 servings 3 servings Zemel et al. Obes Res. 2005;13:1218-25 Zemel et al. Int J Obes. 2005;29:391-7 4 13/05/2013 Methodological factors limiting the generalizability of results: Number of studies Interventions Combination of different dairy products: 5/8 Specification of the fat percentage 1/5 ● Inflammation as the primary outcome or not ● Heterogeneity + lack of detail regarding tested dairy products ● Difference in the amount of dairy products between the “test” and “control” interventions Fat-free yogurt 1/8 Low-fat milk 1/8 ● Differences in the nature and the number of inflammatory markers analyzed in each study Smoothies made with non-fat dry milk 1/8 ● Sensitivity/coefficients of variation of the assays ● Lack of transparency in the report of items associated with the risk of biased results Specific products: ● No distinction between specific dairy products: o milk vs. yogurt vs. cheese o low-fat vs. high-fat dairy products Servings of dairy products/d Consumption Prescribed Actual Methodological factors limiting the generalizability of results: ● Inflammation as the primary outcome or not ● Heterogeneity + lack of detail regarding tested dairy products ● Difference in the amount of dairy products between the “test” and “control” interventions ● Differences in the nature and the number of inflammatory markers analyzed in each study ● Sensitivity/coefficients of variation of the assays ● Lack of transparency in the report of items associated with the risk of biased results Methodological factors limiting the generalizability of results: ● Inflammation as the primary outcome or not ● Heterogeneity + lack of detail regarding tested dairy products ● Difference in the amount of dairy products between the “test” and “control” interventions ● Differences in the nature and the number of inflammatory markers analyzed in each study ● Sensitivity/coefficients of variation of the assays ● Lack of transparency in the report of items associated with the risk of biased results Thompson, Obes Res, 2005 3 diets: • 4 • 4 + fiber • 2 (control) Wennersberg, 2 diets: AJCN, • 3-5 2009 • Habitual diet ● • 3.1 • 3.1 • 1.4 ∆ 1.7 • 1.8-2.5 • 0.8-1.1 ∆ 0.7-1.7 Difference of ≥ 3 servings in dairy products intake between “test” and “control” interventions: o 4/6 studies significant anti-inflammatory effects Cochrane Collaboration’s tool for the assessment of the risk of bias Unclear or high risk of bias (number of studies) Random sequence generation 6/8 Allocation concealment 4/8 Blinding of: Participants 6/8 Personnel 8/8 Outcome assessors 8/8 Incomplete outcome data 2/8 Selective reporting 7/8 Other possible bias: Baseline imbalance 4/8 Carry-over effect 1/2 5 13/05/2013 In summary In summary ● ● Cell culture studies: Randomized controlled nutritional intervention trials: o ↑ production of proinflammatory cytokines ● Observational studies: o Inverse associations between dairy product consumption and inflammation Future perspectives ● Additional nutritional intervention studies: o Adequately powered o Specifically designed to assess the effects of dairy products on inflammation o Better characterization of the type and amount of dairy products tested o Mechanisms underlying the inflammatory response o Inflammation-related gene expression o Dairy product consumption has no adverse effect on the inflammatory profile of overweight or obese adults o Several methodological factors and limitations do not allow differentiation between a beneficial or simply neutral impact of dairy products on inflammation Acknowledgements Systematic review: Benoît Lamarche Patrick Couture Sophie Desroches Caroline Richard PLI study: Team Lamarche: Benoît Lamarche Patrick Couture Marie-Claude Lépine Amélie Charest Audrey Cyr Clinical unit: Steeve Larouche Danielle Aubin Myriam Bouchard Laboratory: Johanne Marin Participants Colleagues from U of Manitoba 6